Quantitative and Qualitative Proteomic Investigations of the Α7 Nicotinic Acetylcholine Receptor by William J. Brucker, III
Total Page:16
File Type:pdf, Size:1020Kb
Quantitative and Qualitative Proteomic Investigations of the α7 Nicotinic Acetylcholine Receptor By William J. Brucker, III Sc.B., Brown University, 2004 Thesis Submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in the Department of Molecular Pharmacology, Physiology & Biotechnology at Brown University PROVIDENCE, RHODE ISLAND MAY 2013 © Copyright 2013 by William J. Brucker, III ii Signature Page This dissertation by William J. Brucker, III is accepted in its present form by the Department of Molecular Pharmacology, Physiology & Biotechnology as satisfying the dissertation requirement for the degree of Doctor of Philosophy. Date _____________ _________________________________ Edward Hawrot, Ph.D, Advisor Recommended to the Graduate Council Date _____________ _________________________________ Wayne Bowen, Ph.D, Reader Date _____________ _________________________________ James Clifton, Ph.D, Reader Date _____________ _________________________________ Nadine Kabbani, Ph.D, Reader Date _____________ _________________________________ Julie Kauer, Ph.D, Reader Approved by the Graduate Council Date _____________ _________________________________ Peter M. Weber, Dean of the Graduate School iii CURRICULUM VITA William J. Brucker, III Dr. Brucker was born in Bethel Park, Pennsylvania in May 1982. He graduated from Brown University in 2004 with a Bachelor of Science with Honors degree in Chemistry. He then matriculated to the MD/PhD program at Brown Medical School. Dr. Brucker also served as an adjunct professor of biology at Rhode Island College from 2007 to 2011. He founded a non-profit organization, Providence Alliance of Clinical Educators, dedicated to improving the quality and applicability of high school science curriculum for students across the country. Dr. Brucker’s distinguished honors include: 2001 Howard Hughes Medical Institute Fellowship, 2002 Brown University Royce Fellowship, 2003 Undergraduate Award for Excellence in Chemistry/ Rhode Island American Chemical Society, 2003 Barry M. Goldwater Scholarship and Excellence in Education Foundation Scholar Award, 2004 Sigma Xi National Scientific Research Honors Society, 2004 “Ivy 50” award for All-time Ivy League Scholar, 2011 Peterson Fund for Educational Enhancement Award. Dr. Brucker has co-authored several peer-reviewed publications as well as anthologies of science parables for educational use. Dr. Brucker is pursuing additional training in Pediatrics in the University of Connecticut Pediatric Residency program. iv ACKNOWLEDGEMENTS To my wife, Stacy, thank you for supporting me through the writing process To Joao Paulo, who aided greatly in the preparation of this dissertation To Dr. Hawrot, thank you for your constant support and guidance. To Dr. Clifton, thanks for being mass spec mentor all of these years. To members of the Hawrot lab past and present, thank you for your company and friendship. v TABLE OF CONTENTS CURRICULUM VITA ............................................................................................................ iv ACKNOWLEDGEMENTS ...................................................................................................... v LIST OF TABLES .................................................................................................................... x LIST OF FIGURES ................................................................................................................. xi LIST OF ABBREVIATIONS .............................................................................................. xiii CHAPTER 1: GENERAL INTRODUCTION ...................................................................... 1 Acetylcholine receptors .............................................................................................................. 2 Nicotinic acetylcholine receptors: subunit stoichiometry and assembly ................ 2 Nicotinic acetylcholine receptor subunit domains and properties ............................ 4 The cytoplasmic loop and signaling ....................................................................................... 5 Function of neuronal nicotinic acetylcholine receptors ................................................. 8 α7 Nicotinic Acetylcholine Receptors ................................................................................. 10 Role in the Hippocampus ................................................................................................................... 13 Intracellular Signaling ......................................................................................................................... 14 Knockout Observations: Cognition, Anxiety, Baroreceptor Response ............................ 17 Non-Neuronal Expression ................................................................................................................. 19 Nicotine and Nicotinic Acetylcholine Receptors............................................................. 20 Burden of Smoking ............................................................................................................................... 20 Nicotine Abuse and Psychiatric Disease ...................................................................................... 22 Pharmokinetics of Nicotine .............................................................................................................. 23 Sensitization and Up-regulation of nAChRs ............................................................................... 23 Nicotine and Reinforcement ............................................................................................................. 24 α7 nAChRs and Nicotine Reinforcement Pathways ................................................................ 25 Withdrawal .............................................................................................................................................. 27 Withdrawal Phenotypes and nAChR Subunits ......................................................................... 27 Oral Nicotine Exposure in a Mouse Model .................................................................................. 28 Metabolism of Nicotine ....................................................................................................................... 29 α7 nAChR targeted smoking cessation therapies .................................................................... 30 Nicotine, Proliferation, and Malignancy ...................................................................................... 30 Nicotine, Arteriogenesis, and Vasculature ....................................................................... 31 Nicotine, α7 nAChRS and Pathologic Vasculogenesis ............................................................ 32 α7 nAChR and Inflammation ................................................................................................. 35 Studies with α7 Specific Agonists and Positive Allosteric Modulators (PAMS)... 37 Effects on Cognition ............................................................................................................................. 38 Effects on Sensory Gating .................................................................................................................. 39 Effects on Nociception ........................................................................................................................ 41 Neuropathic Pain .................................................................................................................................. 41 vi Visceral Pain ............................................................................................................................................ 42 α7 nAChR and Development .................................................................................................. 43 Consequences of Prenatal Nicotine Exposure........................................................................... 43 Nicotinic AChRs and Development ................................................................................................ 44 α7 nAChR Effects on Glutaminergic Synapse Formation ..................................................... 44 α7 nAChR Effect on Chloride Gradient ......................................................................................... 45 α7 nAChR and Neuropathology............................................................................................. 46 Nicotine, α7 nAChR and Anxiety ..................................................................................................... 46 Alzheimer’s Disease ............................................................................................................................. 48 α7 and Schizophrenia .......................................................................................................................... 50 Proteomics ................................................................................................................................... 51 Mass Spectrometry Based Proteomics ............................................................................... 53 Peptide Ionization Techniques ........................................................................................................ 57 Tandem Mass Spectrometry ............................................................................................................. 59 Mass Analyzers ..........................................................................................................................